Evaluation of QuantiFERON-TB Gold Plus on Liaison XL in a Low-Tuberculosis-Incidence Setting
J Clin Microbiol
.
2020 Mar 25;58(4):e00159-20.
doi: 10.1128/JCM.00159-20.
Print 2020 Mar 25.
Authors
E De Maertelaere
1
,
S Vandendriessche
2
,
B Verhasselt
1
3
,
L Coorevits
1
,
E André
4
,
E Padalko
1
3
,
J Boelens
1
3
Affiliations
1
Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
2
Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium
[email protected]
.
3
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
4
Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
PMID:
32024727
PMCID:
PMC7098742
DOI:
10.1128/JCM.00159-20
No abstract available
Keywords:
LTBI; Liaison XL; QuantiFERON-TB Gold Plus.
Publication types
Letter
MeSH terms
Humans
Incidence
Interferon-gamma Release Tests
Latent Tuberculosis*
Tuberculin Test
Tuberculosis* / diagnosis
Tuberculosis* / epidemiology